Invasive Pancreatic Adenocarcinoma with Squamous Differentiation Arising in an IOPN with Novel MDM2 Amplification

被引:0
|
作者
Wilkins, R. [1 ]
Zee, S. [1 ]
机构
[1] NYU, Grossman Sch Med, Pathol, New York, NY USA
关键词
D O I
10.1093/ajcp/aqad150.220
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:S100 / S100
页数:1
相关论文
共 50 条
  • [31] mdm2 oncogene in laryngeal squamous cell carcinoma
    Mastronikolis, Nicholas
    Ragos, Vasileios
    Fotiades, Panagiotis
    Papanikolaou, Vasileios
    Kyrodimos, Efthymios
    Chrysovergis, Aristeidis
    Mastronikolis, Stylianos
    Tsiambas, Evangelos
    JOURNAL OF BUON, 2020, 25 (02): : 594 - 596
  • [32] Novel MDM2 splice variants identified from oral squamous cell carcinoma
    Sam, Kin Kit
    Gan, Chai Phei
    Yee, Pei San
    Chong, Chan Eng
    Lim, Kue Peng
    Karen-Ng, Lee Peng
    Chang, Wei Sern
    Nathan, Sheila
    Rahman, Zainal Ariff Abdul
    Ismail, Siti Mazlipah
    Cheong, Sok Ching
    ORAL ONCOLOGY, 2012, 48 (11) : 1128 - 1135
  • [33] Mdm2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alterations
    Günther, T
    Schneider-Stock, R
    Häckel, C
    Kasper, HU
    Pross, M
    Hackelsberger, A
    Lippert, H
    Roessner, A
    MODERN PATHOLOGY, 2000, 13 (06) : 621 - 626
  • [34] Amplification of the MDM2 gene, but not expression of splice variants of MDM2 mRNA, is associated with prognosis in soft tissue sarcoma
    Bartel, F
    Meye, A
    Würl, P
    Kappler, M
    Bache, M
    Lautenschläger, C
    Grünbaum, U
    Schmidt, H
    Taubert, H
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (03) : 168 - 175
  • [35] Primary Cardiac Intimal Sarcoma: Multi-Layered Strategy and Core Role of MDM2 Amplification/Co-Amplification and MDM2 Immunostaining
    Nistor, Claudiu
    Gavan, Camelia Stanciu
    Birceanu, Adelina
    Betianu, Cezar
    Carsote, Mara
    Cucu, Anca-Pati
    Stanciu, Mihaela
    Popa, Florina Ligia
    Ciuche, Adrian
    Ciobica, Mihai-Lucian
    DIAGNOSTICS, 2024, 14 (09)
  • [36] MDM2 inhibition in combination with MEK inhibition in pre-clinical models of lung adenocarcinomas with MDM2 amplification
    Elkrief, Arielle
    Markov, Vladimir
    Quintanal-Villalonga, Alvaro
    Caeser, Rebecca
    Sobczuk, Pawel
    Cheng, Emily
    Drilon, Alexander
    Riely, Gregory J.
    Lockwood, William W.
    de Stanchina, Elisa
    Rudin, Charles M.
    Odintsov, Igor
    Somwar, Romel
    CANCER RESEARCH, 2023, 83 (07)
  • [37] MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones
    Bahceci, Dorukhan H.
    Jordan, Richard C. K.
    Horvai, Andrew E.
    HEAD & NECK PATHOLOGY, 2022, 16 (04): : 991 - 997
  • [38] MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones
    Dorukhan H. Bahceci
    Richard C. K. Jordan
    Andrew E. Horvai
    Head and Neck Pathology, 2022, 16 : 991 - 997
  • [39] Reactivation of p53 by novel MDM2 inhibitors for pancreatic cancer therapy
    Azmi, Asfar
    Philip, Philip
    Wang, Zhiwei
    Ahmad, Aamir
    Wu, Jiusheng
    Aboukameel, Amro
    Yang, Dajun
    Wang, Shaomeng
    Sarkar, Fazlul
    Mohammad, Ramzi
    CANCER RESEARCH, 2009, 69
  • [40] A rare case of atypical/anaplastic meningioma with MDM2 amplification
    Wylleman, Robbert
    Debiec-Rychter, Maria
    Sciot, Raf
    RARE TUMORS, 2018, 10